SNAP 6383

Drug Profile

SNAP 6383

Alternative Names: L 771688

Latest Information Update: 02 Mar 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Lundbeck Research USA
  • Class
  • Mechanism of Action Alpha 1a adrenergic-receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Benign prostatic hyperplasia

Most Recent Events

  • 02 Mar 2001 Discontinued-II for Benign prostatic hyperplasia in USA (PO)
  • 09 Jun 2000 A study has been added to the Men's Health therapeutic trials and adverse events sections
  • 08 Jun 2000 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top